Team | Year | Age | GS | G | IP | W | L | SV | BS | K | BB | H | HR | K% | BB% | HR% | LOB% | GB% | WHIP | BABIP | ERA | FIP | FIP- | xFIP | E-F | WAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kamloops - WCL (AA)
KAM - WCL (AA)
|
2059 | 26 | 2 | 2 | 10.0 | 0 | 1 | 0 | 0 | 11 | 8 | 3 | 1 | 27.5% | 20.00% | 2.5% | 62.5% | 55.6% | 1.10 | .100 | 4.50 | 5.26 | 120 | 4.90 | -0.76 | 0.03 |
Topeka - CPL (A)
TPK - CPL (A)
|
2058 | 25 | 25 | 25 | 139.1 | 6 | 5 | 0 | 0 | 204 | 69 | 112 | 13 | 33.8% | 11.42% | 2.2% | 79.2% | 71.1% | 1.30 | .361 | 3.49 | 3.70 | 87 | 2.98 | -0.22 | 2.91 |
Topeka - CPL (A)
TPK - CPL (A)
|
2057 | 24 | 1 | 46 | 86.0 | 3 | 2 | 1 | 1 | 123 | 59 | 79 | 14 | 30.9% | 14.82% | 3.5% | 67.8% | 66.1% | 1.60 | .340 | 5.44 | 5.07 | 115 | 3.62 | 0.37 | -0.29 |
Topeka - CPL (A)
TPK - CPL (A)
|
2056 | 23 | 23 | 29 | 134.0 | 8 | 11 | 2 | 2 | 172 | 80 | 120 | 25 | 28.6% | 13.31% | 4.2% | 73.0% | 60.0% | 1.49 | .317 | 5.04 | 5.60 | 124 | 4.03 | -0.56 | 0.23 |
Topeka - CPL (A)
TPK - CPL (A)
|
2055 | 22 | 4 | 34 | 59.1 | 5 | 5 | 16 | 6 | 76 | 34 | 64 | 15 | 28.5% | 12.73% | 5.6% | 73.4% | 64.8% | 1.65 | .371 | 5.76 | 6.12 | 130 | 3.58 | -0.36 | -0.64 |
Ogden - SNL (R)
OGD - SNL (R)
|
2054 | 21 | 13 | 13 | 66.0 | 4 | 2 | 0 | 0 | 91 | 22 | 50 | 13 | 33.6% | 8.12% | 4.8% | 90.3% | 65.7% | 1.09 | .266 | 3.00 | 4.73 | 103 | 3.08 | -1.73 | 0.73 |
Ogden - SNL (R)
OGD - SNL (R)
|
2053 | 20 | 18 | 18 | 62.1 | 1 | 3 | 0 | 0 | 86 | 34 | 52 | 4 | 31.2% | 12.32% | 1.4% | 77.8% | 64.5% | 1.38 | .331 | 3.32 | 3.51 | 91 | 3.37 | -0.19 | 1.13 |
Ogden - SNL (R)
OGD - SNL (R)
|
2052 | 19 | 14 | 14 | 69.2 | 5 | 3 | 0 | 0 | 88 | 31 | 52 | 6 | 30.2% | 10.65% | 2.1% | 84.9% | 57.1% | 1.19 | .282 | 2.20 | 3.42 | 79 | 3.43 | -1.22 | 1.75 |
Ogden - SNL (R)
OGD - SNL (R)
|
2051 | 18 | 4 | 4 | 13.1 | 0 | 2 | 0 | 0 | 17 | 10 | 12 | 1 | 28.3% | 16.67% | 1.7% | 53.4% | 57.1% | 1.65 | .344 | 7.43 | 4.06 | 91 | 4.89 | 3.37 | 0.26 |
Ogden - SNL (R)
OGD - SNL (R)
|
2050 | 17 | 14 | 14 | 54.2 | 2 | 5 | 0 | 0 | 45 | 50 | 44 | 8 | 17.6% | 19.53% | 3.1% | 70.3% | 60.0% | 1.72 | .242 | 4.94 | 6.32 | 135 | 5.90 | -1.39 | -0.44 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2050 | 17 | 6 | 6 | 24.2 | 0 | 3 | 0 | 0 | 30 | 24 | 21 | 4 | 25.9% | 20.69% | 3.4% | 71.8% | 61.5% | 1.82 | .298 | 5.84 | 5.48 | 126 | 5.07 | 0.35 | 0.05 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2049 | 16 | 7 | 11 | 27.2 | 2 | 3 | 0 | 1 | 30 | 32 | 15 | 6 | 22.4% | 23.88% | 4.5% | 66.5% | 51.0% | 1.70 | .143 | 6.51 | 6.64 | 152 | 6.36 | -0.14 | -0.40 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2048 | 15 | 0 | 12 | 27.0 | 2 | 0 | 0 | 0 | 38 | 23 | 14 | 4 | 32.8% | 19.83% | 3.4% | 82.8% | 59.0% | 1.37 | .204 | 3.33 | 4.00 | 95 | 3.65 | -0.67 | 0.17 |
Total - AA
AA
|
2 | 2 | 10.0 | 0 | 1 | 0 | 0 | 11 | 8 | 3 | 1 | 27.5% | 20.00% | 2.5% | 62.5% | 55.6% | 1.10 | .100 | 4.50 | 5.26 | 120 | 4.90 | -0.76 | 0.03 | ||
Total - A
A
|
53 | 134 | 418.2 | 22 | 23 | 19 | 9 | 575 | 242 | 375 | 67 | 30.7% | 12.94% | 3.6% | 73.9% | 65.5% | 1.47 | .343 | 4.71 | 4.93 | 111 | 3.54 | -0.22 | 2.21 | ||
Total - R
R
|
63 | 63 | 266.0 | 12 | 15 | 0 | 0 | 327 | 147 | 210 | 32 | 28.3% | 12.74% | 2.8% | 78.2% | 61.4% | 1.34 | .283 | 3.49 | 4.39 | 100 | 3.91 | -0.91 | 3.43 | ||
Total - HS
HS
|
13 | 29 | 79.1 | 4 | 6 | 0 | 1 | 98 | 79 | 50 | 14 | 26.8% | 21.58% | 3.8% | 73.0% | 56.6% | 1.63 | .213 | 5.22 | 5.38 | 125 | 5.04 | -0.17 | -0.19 | ||
Total - Minors
Minors
|
118 | 199 | 694.2 | 34 | 39 | 19 | 9 | 913 | 397 | 588 | 100 | 29.8% | 12.96% | 3.3% | 75.4% | 63.7% | 1.42 | .316 | 4.24 | 4.73 | 107 | 3.70 | -0.49 | 5.67 |